From the Guidelines
For a 24-month-old with elevated lead levels, immediate confirmation with a venous blood lead level test is essential, and the next steps should be guided by the blood lead concentration level, with a focus on removing the lead source and providing nutritional counseling, as outlined in the AAP guidelines 1. The management of elevated lead levels in children is crucial to prevent long-term neurodevelopmental damage. According to the AAP guidelines, for blood lead levels between 5-14 μg/dL, the recommendation is to:
- Perform steps as described for blood lead concentrations <5 μg/dL, including reviewing laboratory results with the family and providing anticipatory guidance about common sources of environmental lead exposure
- Retest venous blood lead concentration within 1-3 months to verify that the lead concentration is not rising
- Refer the patient to local health authorities if such resources are available
- Take a careful environmental history to identify potential sources of exposures and provide preliminary advice about reducing or eliminating exposures Some key points to consider in the management of elevated lead levels include:
- The importance of nutritional counseling, emphasizing foods rich in calcium, iron, and vitamin C, which can reduce lead absorption
- The need for structured developmental screening evaluations at child health maintenance visits, as lead's effect on development may manifest over years
- The potential for misclassification of children due to laboratory error, and the importance of using tighter performance requirements, such as ±2 μg/dL, to decrease misclassification and improve allocation of healthcare resources For higher blood lead levels, the recommendations include:
- Confirming the blood lead concentration with repeat venous sample within 1-4 weeks for levels between 15-44 μg/dL
- Considering abdominal radiography and gut decontamination for children with a history of pica or excessive mouthing behaviors
- Initiating chelation therapy promptly for levels ≥45 μg/dL, typically with succimer (DMSA) or calcium disodium EDTA, and considering hospitalization for levels ≥70 μg/dL or with encephalopathy, as outlined in the AAP guidelines 1.
From the Research
Next Steps for 24-Month-Old with Elevated Lead
- The first step is to confirm the elevated lead level with a venous blood test, as capillary blood tests can sometimes give false positives 2.
- If the lead level is confirmed to be elevated, the next step is to identify and remove the source of lead exposure 2.
- According to the study by 3, succimer is an orally active, heavy-metal chelating agent that can be used to treat lead poisoning in children with blood lead concentrations higher than 45 micrograms/dL.
- However, the study by 4 found that treatment with succimer did not improve scores on tests of cognition, behavior, or neuropsychological function in children with blood lead levels below 45 microg/dL.
- The Centers for Disease Control and Prevention (CDC) recommends that children with blood lead levels between 20-44 microg/dL receive non-pharmacologic treatment, such as education on lead safety and nutritional counseling 2.
- Chelation therapy with succimer may be considered for children with blood lead levels above 45 microg/dL, but the decision to use chelation therapy should be made on a case-by-case basis, taking into account the child's overall health and the severity of the lead poisoning 3, 5.
- The study by 6 found that oral dimercaptosuccinic acid (succimer) was effective in reducing blood lead concentrations and increasing urine lead excretion in adult patients with inorganic lead poisoning, but the efficacy and safety of succimer in children with elevated lead levels needs to be carefully evaluated.
- It is essential to consult with a healthcare professional to determine the best course of treatment for a 24-month-old child with elevated lead levels.